Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 040860
Company: INGENUS PHARMS NJ
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE 325MG;200MG;16MG TABLET;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
01/07/2010 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
10/07/2019 SUPPL-5 Labeling-Package Insert

Label is not available on this site.

09/21/2018 SUPPL-4 Labeling-Package Insert

Label is not available on this site.

09/18/2018 SUPPL-3 REMS - PROPOSAL - D-N-A

Label is not available on this site.

08/29/2017 SUPPL-2 Labeling-Package Insert

Label is not available on this site.

08/29/2017 SUPPL-1 Labeling-Package Insert

Label is not available on this site.

CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE

TABLET;ORAL; 325MG;200MG;16MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE 325MG;200MG;16MG TABLET;ORAL Prescription No AB 040860 INGENUS PHARMS NJ
CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE 325MG;200MG;16MG TABLET;ORAL Prescription No AB 040118 SANDOZ

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English